SCHEMBL29489752

SCHEMBL29489752

CC(=O)CC(c1ccccc1)c1c(O)oc2cc(O)ccc2c1=O

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 6/20 0.58
ALDH1A1 P00352 4/20 0.55
KDM4E B2RXH2 4/20 0.55
HSD17B10 Q99714 3/20 0.55
ALB P02768 2/20 0.55
MEN1 O00255 2/20 0.55
KMT2A Q03164 2/20 0.55
PCSK7 Q16549 1/20 0.55
VKORC1 Q9BQB6 1/20 0.55
NQO1 P15559 1/20 0.48
BRD4 O60885 1/20 0.47
MAOA P21397 1/20 0.47
CYP3A4 P08684 2/20 0.46
TSHR P16473 2/20 0.46
CYP2C19 P33261 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
MAPT P10636 1/20 0.45
ALOX15 P16050 1/20 0.45
CASP1 P29466 1/20 0.45
CASP7 P55210 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1478281 0.91 CYP2C9 (0.58) CYP2C9ALDH1A1KDM4EHSD17B10ALB
SCHEMBL1479347 0.88 CYP2C9 (0.73) CYP2C9ALDH1A1KDM4EHSD17B10ALB
SCHEMBL136434 0.88 CYP2C9 (0.73) CYP2C9ALDH1A1KDM4EHSD17B10ALB
SCHEMBL20806 0.88 CYP2C9 (0.73) CYP2C9ALDH1A1KDM4EHSD17B10ALB
SCHEMBL17132373 0.84 CYP2C9 (0.77) CYP2C9ALDH1A1KDM4EHSD17B10ALB
Phosphoric Acid SCHEMBL28278851 0.82 CYP2C9 (0.66) CYP2C9ALDH1A1KDM4EHSD17B10ALB
SCHEMBL1477912 0.80 CYP2C9 (0.63) CYP2C9ALDH1A1KDM4EHSD17B10ALB
SCHEMBL43382 0.77 CYP2C9 (0.76) CYP2C9ALDH1A1KDM4EHSD17B10ALB
SCHEMBL1477562 0.77 CYP2C9 (0.76) CYP2C9ALDH1A1KDM4EHSD17B10ALB
SCHEMBL17132372 0.74 CYP2C9 (0.76) CYP2C9ALDH1A1KDM4EHSD17B10ALB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120361022-A Pharmaceutical composition of mulberry bark glycoside C and 7-hydroxy warfarin and application thereof in acute kidney injury 江南大学附属医院 2025-07-25 CN disclosed
CN-120361022-A Pharmaceutical composition of mulberry bark glycoside C and 7-hydroxy warfarin and application thereof in acute kidney injury 江南大学附属医院 2025-07-25 CN disclosed
CN-119136793-A Bile acids and phenylbutyric acid with CYP P450 or transporter substrates for the treatment of amyotrophic lateral sclerosis 艾米利克斯制药公司 2024-12-13 CN disclosed
CN-114008051-B Pyrazolopyrimidine sulfone inhibitors of JAK kinases and uses thereof 豪夫迈·罗氏有限公司 2024-08-13 CN disclosed
WO-2024072778-A1 METHODS AND COMPOSITIONS FOR TREATING AMYOTROPHIC LATERAL SCLEROSIS AMYLYX PHARMACEUTICALS, INC. (US) 2024-04-04 WO disclosed
CN-110678467-B Therapeutic compounds and compositions and methods of use thereof 豪夫迈·罗氏有限公司 2023-06-13 CN disclosed
CN-110650959-B Therapeutic compounds and compositions and methods of use thereof 豪夫迈·罗氏有限公司 2023-04-18 CN disclosed
EP-3986901-A1 PYRAZOLOPYRIMIDINE SULFONE INHIBITORS OF JAK KINASES AND USES THEREOF F. Hoffmann-La Roche AG (CH) 2022-04-27 EP disclosed
CN-114008051-A Pyrazolopyrimidine sulfone inhibitors of JAK kinases and uses thereof 豪夫迈·罗氏有限公司 2022-02-01 CN disclosed